hims & hers fda warning letter compounded semaglutide 2025 Super Bowl ad from and exploits a regulatory gray area Novo Nordisk calls out dangers

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardio-metabolic risk factors between 1980 and 2010: comparative risk assessment

OGTT (Oral Glucose Tolerance Test) blood glucose levels are used to determine whether a woman has Gestational Diabetes Mellitus (GDM)

Some patients literally told me that they felt that they were losing muscle or muscle was slipping away from them while they were on these medications, said researcher Zhenqi Liu, MD, professor of medicine and James M

Less complex hormonal cycling: Womens menstrual cycles create water retention fluctuations that can mask fat loss on the scale

Medicare currently does not cover tirzepatide for weight loss

Survodutide and mazdutide round out the pipeline